Nootropic
Cognizin® Citicoline
Also known as: citicoline, CDP-choline, cytidine diphosphate choline, Cognizin
Cognizin® is a branded form of citicoline, a naturally occurring compound that supports brain energy metabolism and acetylcholine synthesis. It has demonstrated cognitive benefits in clinical research, particularly for attention and mental clarity.
Daily target & upper limit
550 mg / day · UL 3500 mgCognizin® Citicoline has an established daily reference intake. See best forms, label synonyms, upper-limit warnings, and top-scoring supplements:
Cognizin® Citicoline dosage reference →Primary uses
- cognitive enhancement
- mental focus and concentration
- brain energy support
- memory support
- neuroprotection
How it works
- increases acetylcholine synthesis via choline provision
- supports phosphatidylcholine formation in neural membranes
- enhances ATP production in brain mitochondria
- promotes neuronal membrane integrity
Dosage
- Typical range
- 250-500 mg daily
- Timing
- morning or split dose (morning and early afternoon)
- With food
- can be taken with or without food
- Duration
- effects typically observed after 4-12 weeks of consistent use
- Special populations
- Generally well-tolerated; limited safety data in pregnancy/lactation
Forms
- powder· 70/100
- capsule· 70/100
Safety
Common side effects
- headache (rare)
- insomnia (if taken late in day)
- mild gastrointestinal upset
Contraindications
- bipolar disorder (may theoretically exacerbate symptoms)
- concurrent use with certain psychiatric medications requires medical oversight
Products containing Cognizin® Citicoline
Top-scoring supplements in our catalog that list Cognizin® Citicoline on the label. Each product is graded on Formulate's ingredient-level rubric — dose accuracy, form, transparency, and third-party testing.
See all products →Evidence notes
Multiple RCTs show cognitive benefits, particularly for attention and processing speed. Cognizin® specifically has peer-reviewed human clinical data supporting efficacy at standardized doses.
Grade B: Some human trials support key claims; further confirmation needed.
Cited research for Cognizin® Citicoline
Clinical studies referenced across Formulate guides that mention cognizin® citicoline. Each links to the full study page with PubMed source + the guides that cite it.
- Alvarez-Sabin et al. (2013)Journal of the Neurological Sciences
Citicoline for acute ischemic stroke: long-term use for post-stroke cognitive function
- McGlade et al. (2012)Food and Nutrition Sciences
Improved attentional performance following citicoline administration in healthy adult women
- Okuda et al. (1973)Journal of Pharmacy and Pharmacology
Distribution and metabolism of CDP-choline in rats
Related in Nootropic
Check a full stack
Formulate's free interaction checker lets you paste in any combination of supplements and medications at once — every pairing flags severity, timing, and cited evidence.
Open the checkerMedical disclaimer. This page is educational and does not replace advice from a qualified healthcare provider.
